AW
UTHR icon

Avion Wealth’s United Therapeutics UTHR Stock Holding History

Avion Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Hold
9
– – ﹤0.01% 687
2025
Q4 		$4K Sell
9
-4
-31% -$1.86K ﹤0.01% 746
2025
Q3 		$5K Sell
13
-69
-84% -$23.2K ﹤0.01% 669
2025
Q2 		$23K Buy
82
+73
+811% +$21.8K 0.01% 297
2025
Q1 		$3K Hold
9
– – ﹤0.01% 676
2024
Q4 		$3K Buy
9
+2
+29% +$735 ﹤0.01% 673
2024
Q3 		$2K Buy
7
+1
+17% +$338 ﹤0.01% 727
2024
Q2 		$1K Sell
6
-2
-25% -$529 ﹤0.01% 832
2024
Q1 		$2K Hold
8
– – ﹤0.01% 789
2023
Q4 		$2K Hold
8
– – ﹤0.01% 635
2023
Q3 		$1K Buy
8
+2
+33% +$461 ﹤0.01% 747
2023
Q2 		$0 Buy
+6
New +$1.33K ﹤0.01% 1046

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Avion Wealth's UTHR Position: Q1 2026 in Review

Avion Wealth held its United Therapeutics (UTHR) position steady in Q1 2026 at 9 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Avion Wealth first reported a position in UTHR in Q2 2023 and has held it in 12 quarters since. The position peaked at $23K in Q2 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Avion Wealth held 9 shares of United Therapeutics worth $5K as of Q1 2026.
  • Avion Wealth left its United Therapeutics share count unchanged in Q1 2026.
  • United Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #687 holding.
  • Avion Wealth first reported a position in United Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Avion Wealth's United Therapeutics position peaked at $23K in Q2 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.